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Objective. To evaluate the clinical efficacy of laryngeal nerve (LN) monitoring (LNM) during total endoscopic thyroidectomy via
breast approach, with emphasis on the identification rates for RLN and EBSLN and the incidence of RLN paralysis.Materials and
Methods.This retrospective study included 280 patients who underwent endoscopic thyroidectomywith or without LNM. RLN and
EBSLN were identified using endoscopic magnification in the control group, while they were localized additionally by LNM in the
LNM group. Demographic parameters and surgical outcomes were analyzed by statistical methods. Patients in the control group
were also stratified by the side of thyroidectomy to determine difference in left and right RLN injury rates. Results. All procedures
were successfully conducted without permanent LN damage. The identification rates for RLN and EBSLN were high in the LNM
group compared to those of the control group, and the risk difference (RD) of temporary RLN injury between two groups was 6.3%.
The risk of damage was slightly higher for the left RLN than for the right RLN in the control group, which was performed by a right-
hand surgeon. Conclusion.The joint application of LNM and endoscopic magnified view endows total endoscopic thyroidectomy
with ease, safety, and efficiency.
1. Introduction
Thyroid surgery has long been considered an effective treat-
ment option for malignant thyroid diseases. The fast evolve-
ment of medical technologies and instruments, such as min-
imally invasive surgical techniques and ultrasonic scalpels,
has enabled a smaller incision length or incision placement
at hidden sites away from the neck, resulting in nonevi-
dent scars. Minimally invasive thyroid surgery ranges from
minimally invasive video-assisted thyroidectomy (MIVAT)
to complete endoscopic thyroidectomy, and, compared
with conventional procedures, it offers superior esthetics,
decreased postoperative pain, and shortened hospitalization
time. Endoscopic thyroidectomy via chest-breast approach
or areola of breast approach, although not strictly minimally
invasive, is welcomed by beauty-conscious patients world-
wide. However, injuries to the external branch of the superior
laryngeal nerve (EBSLN) and recurrent laryngeal nerve
(RLN) are still well-defined hazards in endoscopic thyroid
surgery. Postoperative symptoms of hoarseness, dyspnea, and
dysphagia primarily indicate RLN damage, which can also
remain asymptomatic in some cases. The rate of permanent
RLN paralysis and the incidence of transient RLN palsy after
thyroidectomy have been reported as 0.3%–3% and 5%–8%,
respectively [1]. EBSLN injury may decrease the range of
vocal cord vibration frequencies, consequently affecting the
capability to generate a higher vocal register and decreasing
voice projection. This nerve injury reportedly occurs in up
to 58% patients during dissection or ligation of the superior
thyroid pedicle [2, 3]. Visualization of the laryngeal nerve
(LN) during surgery will aid in decreasing the incidence of
nerve injury to some extent [4]. To date, numerous tech-
niques to enhance intraoperative LN identification, which
require special instruments and additional procedures during
neck surgery, have been introduced and improved, including
the use of commercially available electromyography endotra-
cheal tube (ETT) and paired nerve monitoring (NM) system.
Several studies have reported that LN monitoring (LNM)
during conventional thyroidectomy enables the reliable local-
ization of both EBSLN and RLN, with improved neurological
outcomes [5, 6]. However, to the best of our knowledge, the
effectiveness of LNM during total endoscopic thyroidectomy
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via the breast approach has not been assessed. Therefore,
we conducted this study to evaluate the clinical efficacy of
LNM during total endoscopic thyroidectomy via the breast
approach, with emphasis on the identification rates for RLN
and EBSLN and the incidence of RLN paralysis.
2. Materials and Methods
2.1. Patients. In order to avoid bias due to variable complexity
in the surgical technique and guarantee standardization of all
patients, we adhere to strict inclusion criteria as follows: age
≤ 45 years, presence of benign thyroid nodules measuring ≤
4 cm or malignant lesions measuring ≤ 2 cm in their largest
diameter, absence of cervical lymphadenopathy, no history
of previous neck surgery, no comorbidity of Hashimoto’s
thyroiditis (HT), and absence of extrathyroidal metastases.
The medical records of patients who underwent endoscopic
thyroid surgery via the areola of breast approach at Qilu
Hospital of Shandong University between January 2010 and
January 2014 were retrospectively reviewed for patient demo-
graphics, volume of the treated thyroid, dominant nodule
size, surgical scope (lobectomy versus total thyroidectomy),
mean duration of the critical operating procedure, and
neurological complications. In our study, all procedures were
approved by Medical Ethics Committee of Qilu Hospital of
ShandongUniversity. Patients were diagnosed by ultrasonog-
raphy (USG) and thyroid function test and provided written
consent to undergo this surgical method after receiving an
explanation of the risks and benefits. Patients with malignan-
cies received thyroid stimulating hormone (TSH) suppressive
therapy after surgery. Hormone replacement therapy was
administered to patients with benign nodules.
2.2. Surgical Technique. All patients underwent endoscopic
thyroid surgery under general anesthesia. We have been
administering a half-dose neuromuscular blocking agent
during the induction of anesthesia at our department since
2010, while we have been employing intraoperative nerve
monitoring and stimulation using the NIM 3.0 (Medtronic
Inc., Minnesota, USA) in most patients since 2012. For this,
intracutaneous grounding electrodes were inserted in the
right upper arm. A specialized ETT was accurately placed
such that the surface electrode was in contact with the
true vocal cords, and the integrity of the NM system was
confirmed by tapping test. Then, three incisions were placed
along the margins of areola. One was an observation hole
at the medial border of the right areola for videoendoscopy
and removal of the specimen, while two operation holes
were at the bilateral areola borders. The 30∘ 10-mm endo-
scope (Olympus Inc., JPN) was inserted and subcutaneously
advanced for a distance of 20 cm with 2.4% ropivacaine and
0.2% epinephrine previously impregnating the subcutaneous
tunneling. A puncture path was prepared in the anterior
cervical midline, 3 cm above the sternal notch, to insert
the pulse-generated monopolar probe. The surgical team
included an intermediate grade general surgeon and two
assistants specialized in endocrine surgery, and all procedures
were meticulously performed with thorough hemostasis. En
bloc lobectomy was achieved under adequate surgical field
exposure using specialized retractors.
2.3. Nerve Identification. We routinely visualize but do not
seal the superior and inferior thyroid arteries until LNs are
exposed. In the control group, RLN and EBSLN were solely
identified using endoscopicmagnification, while, in the LNM
group, they were identified using magnification through the
endoscope and the NM system at the time of nerve dissection
or thyroid vessels sealing. Neural stimulating responses were
recorded according to the four-step routine (V1: initial vagal
stimulation; R1: initial RLN stimulation; R2: after thyroid
lobectomy or central compartment lymphadenectomy, as
well as V2).The cosine wave and audio feedback outputted by
the monitor alerted us to RLN proximity during anatomical
dissection, while an audible signal and corresponding twitch
of the cricothyroid muscle indicated the integral function
of EBSLN. In the control group, the initial and final LNs
identificationwas accomplished by endoscopicmagnification
only, while, in the LNM group, the initial LNs identification
was prior to neural stimulation and the final after neural
stimulation.
2.4. Assessment of Nerve Function. Evaluation of vocal cord
motionwas standardized by performing laryngoscopy within
3 days before and after the surgery [7]. All evaluations were
performed by a consulting head and neck surgeon. Any
decrease in vocal cord mobility was identified as paralysis.
Affected patients underwent a 1-year follow-up with the
written consents, with visits scheduled at 1-month intervals.
Temporary RLN injury was defined as vocal cord dysfunction
that resolved within 6 months, while permanent RLN injury
was defined as persistent vocal cord dysfunction for >6
months.
2.5. Data Collection and Statistical Analysis. Patient age,
nodule diameter, volume of treated thyroid, and duration
of the critical operating procedure are expressed as means
± standard deviations (SDs). The volume of treated thyroid
was calculated for all patients using the following formula:
volume = 𝑓× (𝐴×𝐵×𝐶) × 10−3mL. Here, 𝑓 is the correction
coefficient for the elliptic model, which is assigned 𝜋/6 =
0.524, and 𝐴, 𝐵, and 𝐶 represent the maximal dimensions
assessed by USG in two mutually perpendicular planes
[8]. The duration of the critical operating procedure was
defined as the time period from exposure of the affected
lobe to en bloc removal. Cross-tabulation analysis with the
𝜒
2 test or Fisher’s exact test was performed to validate the
comparability of the two groups. Differences in surgical data
were analyzed using Student’s 𝑡-test. A 𝑃 value of <0.05 was
considered statistically significant.
3. Results
In total, we reviewed the records of 282 patients with no
history of voice problems resulting from vocal cord palsy,
nodules, or polyps. One patient developed hoarseness due to
arytenoid dislocation and exhibited full recovery finally. Two
patients were excluded because they developed a fluctuating
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Table 1: Demographic parameters and surgical data.
Control group LNM group P
Demographic parameters
Age (years) 30.33 ± 6.65 28.90 ± 6.53 0.21
Male (%) 7 (4.5%) 4 (3.2%) 0.76a
Female (%) 149 (95.5%) 120 (96.8%)
USG findings
Volume of treated thyroid (mL) 14.05 ± 8.57 (2.91–28.06) 13.31 ± 9.02 (2.53–29.01) 0.48
Dominant nodule diameter (cm) 1.81 ± 0.84 (0.4–3.5) 1.69 ± 0.87 (0.3–3.8) 0.23
Techniques employed
Hemithyroidectomy (%) 127 (81.4%) 92 (74.2%) 0.15
Total thyroidectomy (%) 29 (18.6%) 32 (25.8%)
Duration of surgery (min) 39.87 ± 5.39 40.77 ± 4.42 0.13
Postoperative follow-up by fibrolaryngoscopeb
Transient RLN injury 14 2
<0.01
Normal vocal cords condition 171 154
USG: ultrasonography; RLN: recurrent laryngeal nerve; LNM: laryngeal nerve monitoring.
aFisher’s exact test.
bThe number of nerves at risk, not the number of patients, was counted.
neck mass due to thermal damage of trachea and underwent
prompt repair for tracheal rupture. Eventually, we included
156 patients in the control group and 124 patients in the
LNM group. In the control group, 127 patients (81.4%)
underwent hemithyroidectomy, with or without central com-
partment lymphadenectomy and 29 (18.6%) underwent total
thyroidectomy, with or without unilateral or bilateral cen-
tral compartment lymphadenectomy, resulting in 185 nerves
at risk (NARs). In the LNM group, 92 patients (74.2%)
underwent a hemithyroidectomy and 32 (25.8%) underwent
total thyroidectomy, both combined with or without central
compartment lymphadenectomy, and this resulted in 156
NARs. There were no differences with regard to age, sex, and
the pathological condition between the two groups (Table 1,
𝑃 > 0.05 for all). Furthermore, all cases exhibited a similar
degree of technical difficulty, as assessed from the volume
of the treated thyroid (𝑃 = 0.48), nodule size (𝑃 = 0.23),
and extent of surgery (𝑃 = 0.15). Although suspected benign
nodules (largest diameter: >2 cm) were verified to be malig-
nant by frozen section analysis in some patients, leading to a
deviation from our inclusion criteria, there was no significant
impact on the comparability of the two groups (Table 2).
Clinical examinations revealed that no case of permanent
RLN paralysis existed. Neural traction, heat conduction, and
other ischemic nerve lesions resulted in a temporary RLN
paresis rate of 7.57% (14 of 185NARs) in the control group and
1.28% (two of 156 NARs) in the LNM group. This incidence
was equally distributed throughout the research period, with
no apparent subjective bias (nine cases in the first 140 patients
and seven in the remaining). As shown in Table 1, LNM is an
added protection to RLN (odds ratio (OR): 0.16; 95% confi-
dence interval (CI): 0.04–0.71; observed power: 0.87) which
yields a risk difference (RD) of 6.3% between two groups (𝑃 <
0.01), while the duration of the critical operating procedure
showed no such difference (𝑃 = 0.13).
Table 2: Pathological findings in patients with and without intraop-
erative LNM.
Treated pathology Control group LNM group P
Nodular goiter (%) 47 (30.1%) 35 (28.2%)
0.74Thyroid adenoma (%) 20 (12.8%) 13 (10.5%)






DTC: differentiated thyroid carcinoma; T1-T2, Nx–N1a: pathological staging
according to the 7th edition of the AJCC TNM staging system; Nx: no
palpable cervical lymph node or no lymphadenectomy.
aSuspected benign nodules that were pathologically proven malignant, not
fulfilling our eligibility criteria.
With regard to the efficacy of intraoperative neuromon-
itoring, the visual identification rates (identifying nerve by
endoscopic magnification only) for both RLN and EBSLN
were not significantly different between the two groups when
only endoscopic magnification was used (𝑃 > 0.05 for all).
Although statistical analysis indicated a slight difference in
the final identification rate of RLN of two groups (𝑃 = 0.03),
it seemed to be of no clinical significance (97.4% versus 100%,
𝑃 = 0.12). However, evidently greater number of EBSLNs,
which were not previously detected, were identified under
LNM (Table 3,𝑃 < 0.01). At the same time, the number of left
RLNpalsies was observed to be greater than that of right RLN
palsies. Accordingly, the control group was further divided
into right and left lobectomy groups, and the incidence of left-
sided palsy was higher (𝑃 = 0.04), even though the difference
was not obviously significant (Table 4).
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Table 3: Efficacy of LNM (identification of 341 NARs).
Control
group LNM group P
Initial visual ID of
RLN (%)
179/185
(96.8%) 152/156 (97.4%) 0.76
a
Final ID of RLN (%) 179/185(96.8%) 156/156 (100%) 0.03
a
P — 0.12a —
Initial visual ID of
EBSLN (%)
73/185
(39.5%) 67/156 (42.9%) 0.51
Final ID of EBSLN
(%)
73/185
(39.5%) 118/156 (75.6%) <0.01
P — <0.01 —
ID: identification; NAR: nerve at risk; LNM: laryngeal nerve monitoring;
RLN: recurrent laryngeal nerve; EBSLN: external branch of the superior
laryngeal nerve.
aFisher’s exact test.
Table 4: Characteristics of patients stratified by thyroidectomy side
(only for the control group).
Left lobectomy Rightlobectomy P
Age (years) 30.12 ± 6.41 30.32 ± 6.72 0.84
Male (%) 5 (7.1%) 2 (2.0%) 0.25a













Transient RLN injury 10 4 0.04
Normal vocal cords
condition 74 97
RLN: recurrent laryngeal nerve.
aFisher’s exact test.
4. Discussion
Endoscopic thyroidectomy was introduced at our institute in
2010, and we have gradually and comprehensively mastered
the procedure since then. An average of 93 endoscopic
thyroid operations a year were performed by us now. Intra-
operative NM was introduced in 2012 and became a routine
practice and a basic item included in the consent procedure
before surgery; since then, an increasing number of patients
was convinced to experience this new nerve andmuscle stim-
ulation technique, which helped us in completing our retro-
spective study.We evaluated the clinical efficacy of LNMdur-
ing total endoscopic thyroidectomy via the breast approach
and found a significant improvement in the RLN and EBSLN
detection rates with this modality.
Intraoperative RLN identification has long been credited
with the benefit of decreasing the incidence of postoperative
nerve paresis. Because endoscopic surgery offers a small
space for surgical manipulation, stringent safety measures
against nerve exposure are essential. In the LNM group, we
routinely perform neural mapping (probing for RLN) until
the entire course of RLN is exposed, and the incidence of
temporary paresis decreased from 7.6% to 1.3% (RD, 6.3%) in
our study. However, these results are limited by the inclusion
of a relatively small sample size and nonrandomized design.
In addition, though cases suffering RLN permanent injury
were equally distributed throughout the research period
(nine cases in the first 140 patients and seven in the remain-
ing), we have become more experienced with the endoscopic
technique over time and the improved outcomes in the LNM
group could be in part due to this experience. However, dura-
tion of surgery was not different and that nerve injury did not
decrease over time in the control group, which would argue
against this. A prospective study with a larger cohort, similar
to the study by Lorenz et al. [9], is necessary to rule out con-
founding factors (body mass index (BMI) and neck length)
by stratified analysis or multiple logistic regression analysis
and further clarify the advantages of LNM for both patients
and less experienced surgeons. Terris et al. reported that the
current incidence of postoperative vocal cord palsy is very
low (1%-2%), necessitating a sample of approximately 1000
patients to determine a 1% decrease in the nerve injury rate
[10].
Loss of neuromonitoring signal (visual and audio feed-
back vanished) often alludes RLN injury, either transient or
permanent one. Signal failing to be restored (no R2 and V2
signal or R2 ≤ 1/2 R1) in 20min is deemed to be nerve palsy,
and the operation is terminated in total thyroidectomy. If
needed, a second surgery resecting the other affected lobe
is performed until the former paralytic nerve is restored. In
those cases, we only enrolled the initial operation data into
our study. Signal restoring (R2 ≥ 1/2 R1) in 20min commonly
occurs and is deemed to be normal condition.
LNM facilitates the identification of nerves at each step of
dissection and ligation, resulting in safe and easy endoscopic
surgery without inadvertent ligature, clamping, or heat or
suction injury in most cases. In addition, LNM aids in docu-
menting the status of RLN, which can be used as a reference
in case of secondary intervention. In fact, we also recommend
LNM for patients with latent nonrecurrent LN associated
with a retroesophageal right subclavian artery, those with
previous neck surgery or irradiation, thosewith palpable lym-
phadenopathy, and those with nodules showing RLN inva-
sion or compression on USG and requiring open thyroidec-
tomy. However, young surgeons should utilize this technique
as an adjunct to understandmore about the complex anatomy
of RLN rather than relying on it completely, because the cost
of this procedure is not yet covered by the Chinese health
insurance system.
EBSLN is also at risk of inadvertent injury during thy-
roidectomy, although clinical trials have shown a low injury
rate [3]. It is routinely probed and dissected until a portion of
nerve is exposed at our institute, with corresponding contrac-
tion of the cricothyroid muscle during stimulation used as an
indicator of an intact EBSLN. In our study, the rate of EBSLN
localization increased from 42.9% to 75.6%with LNM, which
might decrease the incidence of superior laryngeal nerve-
(SLN-) related complications. This finding is consistent with
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the findings of Barczyński et al. [2] who reported the effec-
tiveness of SLNmonitoring in open thyroidectomy, where the
postoperative video stroboscopy and videokymography were
used to indicate an intact EBSLN.However, the costs of deter-
mining SLN injury (either intraoperative nerve monitoring
and stimulation or the postoperative video stroboscopy and
videokymography) in our healthcare environment are high;
furthermore, the diagnostic value of patients’ subjective
complaints is low, which impedes further investigations [11].
In the present study, we statistically evaluated the dura-
tion of the critical operating procedure, which included the
procedure between exposure of the affected thyroid and en
bloc removal, and found no significant difference between the
LNM and control groups. However, we followed a four-step
LNM procedure (V1-R1-R2-V2) to complete the most time-
consuming and delicate process during lobectomy, that is,
RLN dissection. The surgeons involved in these procedures
had accumulated sufficient surgical experience, and this
resulted in a decreased surgical duration, decreased blood
loss, and few postoperative complications and compensated,
at least in part, for the time consumed by LNM.
We also evaluated patients stratified by the side of thy-
roidectomy to clarify the suspected tendency of increased
left RLN paresis in the control group and found no obvious
significant difference. If certain unknown confounders are
excluded, this phenomenon can be explained as follows. First,
the left RLN travels within the tracheoesophageal groove
(TEG), whereas the right RLN courses anterior to TEG.
Therefore, the left RLN is relatively better protected from lig-
ation and retractor-induced trauma during open thyroidec-
tomy [12]. However, the opposite is true during endoscopic
surgery because of a small surgical field, increased lobe trac-
tion due to deeper and longer course of the RLN on the left,
and deeper dissection using an ultrasonic scalpel. Second,
right-hand surgeons stand between the patient’s legs and
insert the ultrasonic scalpel through a hole created on the left.
The medial margin of the right lobe is pulled outwards, and
the right RLN is just located under the surface tissue, whereas
the lateral border of left lobe was drafted toward the midline,
and some tract-like tissues may stretch or compress nerve
to the trachea, leading to more stretch injuries and corre-
sponding temporary paralyses.Third, the six patientswith left
RLN damage exhibit a higher BMI or a short neck, leading to
further bias. In addition, prospective studies are necessary to
verify these speculations.
In conclusion, the results of our study suggest that LNM
is a sensitive and nerve-specific tool that decreases the
incidence of complications associated with SLN and RLN
damage during minimally invasive thyroid surgery restricted
to the central neck compartment, particularlywhen surgery is
performed by inexperienced surgeons. It endows endoscopic
thyroidectomy with ease, safety, and efficiency.
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